Bristol-Myers Squibb Co., of New York, named Francis Cuss executive vice president and chief scientific officer, effective July 1...EntreMed Inc., of Rockville, Md., appointed Ken K. Ren CEO, and added James Huang and Y. Alexander Wu to its board

Alexza Pharmaceuticals Inc., of Mountain View, Calif., added Peter W. Schineller as senior vice president and chief commercial officer...Cardiome Pharma Corp., of Vancouver, British Columbia, appointed William Hunter president and CEO and promoted Karim Lalji to chief commercial officer

Intercept Pharmaceuticals Inc., of New York, appointed Daniel Regan chief commercial officer...ValiRx plc, of London, appointed Samuel Ogunsalu chief commercial officer

Rexahn Pharmaceuticals Inc., of Rockville, Md., named Peter D. Suzdak CEO and Chang AHN chief scientist...Spectrum Pharmaceuticals Inc., of Henderson, Nev., named Joseph Turgeon senior vice president and chief commercial officer

AMAG Pharmaceuticals Inc., of Lexington, Mass., appointed Greg Madison executive vice president and chief commercial officer...OvaScience Inc., of Cambridge, Mass., named Alison Lawton chief operating officer and Christopher Beck chief commercial officer

ImmunoCellular Therapeutics Ltd., of Los Angeles, named Andrew Gengos president and CEO...uniQure BV, of Amsterdam, the Netherlands, appointed Hans Christian Rohde chief commercial officer

Anne-Marie Swift will serve as vice president and European marketing director...Saladax Biomedical Inc., of Bethlehem, Pa., appointed Mark D. Myslinski senior vice president and chief commercial officer

A.P. Pharma Inc., of Redwood City, Calif., named Robert Rosen senior vice president and chief commercial officer...Fate Therapeutics Inc., of San Diego, appointed Christian Weyer president and CEO

Imprimis Pharmaceuticals Inc., of Solana Beach, Calif., added Lee S. Simon and Allan Green to its science and regulatory advisory board...Islet Sciences Inc., of New York, added Kevan Herold and Morton Printz to its scientific advisory board

Eli Lilly and Co., of Indianapolis, named Michael Harrington senior vice president and general counsel...Vertex Pharmaceuticals Inc., of Cambridge, Mass., appointed Stuart Arbuckle executive vice president and chief commercial officer

BioMotiv LLC, of Cleveland, named Baiju R. Shah CEO and board member, effective Sept...CombiMatrix Corp., of Irvine, Calif., named Mark McDonough chief commercial officer

Mark Oki senior vice president, finance and chief financial officer...Endocyte Inc., of West Lafayette, Ind., named David Meek chief commercial officer

Galena Biopharma Inc., of Lake Oswego, Ore., named Rosemary Mazanet executive vice president and chief medical officer and appointed Robert Figlin to its scientific advisory board...Incline Therapeutics Inc., of Redwood City, Calif, named John Tucker senior vice president and chief commercial officer

Northwest Biotherapeutics, of Bethesda, Md., added Navid Malik and Jerry Jasinowski to its board...QLT Inc., of Vancouver, British Columbia, appointed Christopher Muller chief commercial officer

Constellation Pharmaceuticals Inc., of Cambridge, Mass., named Keith Dionne president and CEO and Mark Goldsmith executive chairman of the board...Intermune Inc., of Brisbane, Calif., added Jean-Jacques Bienaime and Frank Verwiel to its board...OvaScience, of Cambridge, Mass., added Jeffrey Capello and John Simon to its board

Avanir Pharmaceutics Inc., of Aliso Viejo, Calif., appointed Rohan Palekar senior vice president and chief commercial officer...Novavax Inc., of Rockville, Md., named John Hermann vice president and general counsel

CombiMatrix Corp., of Irvine, Calif., appointed Richard Ding and Joseph Limber to its board...and Christine Mikail, executive vice president, corporate development, general counsel and secretary

Micromet Inc., of Rockville, Md., appointed Joseph Lobacki senior vice president and chief commercial officer...NexImmune Inc., of Gaithersburg, Md., appointed Kenneth Carter CEO and named Jonathan Schneck chairman of the clinical and scientific advisory board

Micromet Inc., of Rockville, Md., appointed Joseph Lobacki senior vice president and chief commercial officer...NexImmune Inc., of Gaithersburg, Md., appointed Kenneth Carter CEO and named Jonathan Schneck chairman of the clinical and scientific advisory board